2022
-
Hemostemix’s stem cell therapy pursues ‘Your Fountain of Youth’
What’s a company worth to investors that could improve numerous medical conditions related to ischemia (lack of blood…
-
Dev Randhawa provides an update on Fission 3.0 and discusses uranium and sustainability
In a recent InvestorIntel interview, Tracy Weslosky interviews Fission 3.0 Corp.’s (TSXV: FUU | OTCQB: FISOF) Chairman and…
